1. Home
  2. ANNX vs NAK Comparison

ANNX vs NAK Comparison

Compare ANNX & NAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Annexon Inc.

ANNX

Annexon Inc.

HOLD

Current Price

$5.79

Market Cap

972.5M

Sector

Health Care

ML Signal

HOLD

Logo Northern Dynasty Minerals Ltd.

NAK

Northern Dynasty Minerals Ltd.

HOLD

Current Price

$2.07

Market Cap

1.1B

ML Signal

HOLD

Company Overview

Basic Information
Metric
ANNX
NAK
Founded
2011
1983
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Precious Metals
Sector
Health Care
Basic Materials
Exchange
Nasdaq
Nasdaq
Market Cap
972.5M
1.1B
IPO Year
2020
2002

Fundamental Metrics

Financial Performance
Metric
ANNX
NAK
Price
$5.79
$2.07
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
2
Target Price
$16.50
$2.50
AVG Volume (30 Days)
2.2M
9.6M
Earning Date
05-11-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$16,320.74
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.60
$0.73
52 Week High
$7.18
$2.98

Technical Indicators

Market Signals
Indicator
ANNX
NAK
Relative Strength Index (RSI) 47.71 61.96
Support Level $4.79 $1.83
Resistance Level $6.56 $2.17
Average True Range (ATR) 0.29 0.12
MACD -0.06 -0.00
Stochastic Oscillator 8.43 56.94

Price Performance

Historical Comparison
ANNX
NAK

About ANNX Annexon Inc.

Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502, for Oral small molecule; and ANX009, for systemic autoimmune diseases.

About NAK Northern Dynasty Minerals Ltd.

Northern Dynasty Minerals Ltd is a mineral exploration company. It has a single operating segment of acquisition, exploration, and development of mineral properties. Its core asset is the Pebble Project located in Alaska, USA. The Pebble project is seeking to develop a deposit of copper, gold, molybdenum, and silver into a modern mining operation.

Share on Social Networks: